Academic Journals Database
Disseminating quality controlled scientific knowledge

Chemokines as Cancer Vaccine Adjuvants

Author(s): Iuliana D. Bobanga | Agne Petrosiute | Alex Y. Huang

Journal: Vaccines
ISSN 2076-393X

Volume: 1;
Issue: 4;
Start page: 444;
Date: 2013;
Original page

Keywords: chemokines | dendritic cell | immunotherapy | cancer vaccine | adjuvant

We are witnessing a new era of immune-mediated cancer therapies and vaccine development. As the field of cancer vaccines advances into clinical trials, overcoming low immunogenicity is a limiting step in achieving full success of this therapeutic approach. Recent discoveries in the many biological roles of chemokines in tumor immunology allow their exploitation in enhancing recruitment of antigen presenting cells (APCs) and effector cells to appropriate anatomical sites. This knowledge, combined with advances in gene therapy and virology, allows researchers to employ chemokines as potential vaccine adjuvants. This review will focus on recent murine and human studies that use chemokines as therapeutic anti-cancer vaccine adjuvants.
Why do you need a reservation system?      Save time & money - Smart Internet Solutions